2021
DOI: 10.3389/fimmu.2020.624547
|View full text |Cite
|
Sign up to set email alerts
|

Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition

Abstract: ContextDue to recent advantages in cancer therapy, immune checkpoint inhibitors (ICIs) are new classes of drugs targeting programmed cell death protein 1 (PD-1) or its ligand programmed cell death protein 1-ligand 1 (PD-L1) used in many cancer therapies. Acute interstitial nephritis (AIN) is a potential and deleterious immune-related adverse events (irAE) in the kidney observed in patients receiving ICIs and the most common biopsy-proven diagnosis in patients who develop acute kidney injury (AKI). Based on pre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 19 publications
(29 citation statements)
references
References 14 publications
1
27
1
Order By: Relevance
“…A total number of 148 kidney biopsies with various intrarenal renal pathologies including 53 cases with ANCA GN at the University Medical Center Göttingen were retrospectively included between 2015 and 2020, the patient cohort has previously been described [ 45 , 61 , 62 , 63 ]. While no formal approval was required for the use of routine clinical data, a favorable ethical opinion was granted by the local Ethics committee (protocol codes: 22/2/14, approval date 22 September 2014 and 28/09/17, approval date 17 November 2017).…”
Section: Methodsmentioning
confidence: 99%
“…A total number of 148 kidney biopsies with various intrarenal renal pathologies including 53 cases with ANCA GN at the University Medical Center Göttingen were retrospectively included between 2015 and 2020, the patient cohort has previously been described [ 45 , 61 , 62 , 63 ]. While no formal approval was required for the use of routine clinical data, a favorable ethical opinion was granted by the local Ethics committee (protocol codes: 22/2/14, approval date 22 September 2014 and 28/09/17, approval date 17 November 2017).…”
Section: Methodsmentioning
confidence: 99%
“…A total number of 53 kidney biopsies with ANCA GN at the University Medical Center Göttingen were retrospectively included between 2015 till 2020; the patient cohort has previously been described (16)(17)(18)(19)(20)(21). While no formal approval was required for the use of routine clinical data, a favorable ethical opinion was granted by the local Ethics committee (no.…”
Section: Study Populationmentioning
confidence: 99%
“…A total of 53 kidney biopsies with ANCA GN at the University Medical Center Göttingen were retrospectively included between 2015 and 2020, the patient cohort was previously described (19)(20)(21)(22)(23)(24)(25). While no formal approval was required to use routine clinical data, a favorable ethical opinion was granted by the local Ethics committee (protocol no.…”
Section: Study Populationmentioning
confidence: 99%
“…(15-20.5). The median (IQR) SAPS II at admission was 24(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32), and 24/53 (45.3%) of patients required ICU supportive care. There were 44/53 patients (83%) with some extrarenal manifestation of AAV (31 with lung, 9 with sinus, 12 with joint, 4 with ear, 3 with eye, 6 with peripheral nerve, and 9 with skin involvement), and 7/53(13.2%) had alveolar hemorrhage.…”
mentioning
confidence: 99%